Merck’s Experimental Insomnia Pill Looks to Top Ambien

An experimental insomnia drug from Merck & Co. that’s designed to turn off wakefulness rather than subdue the brain into slumber, helped people fall and stay asleep, according to results from two clinical trials.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.